GP admits to falsifying clinical trial of insomnia drugBMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i2441 (Published 27 April 2016) Cite this as: BMJ 2016;353:i2441
- Clare Dyer
- The BMJ
A GP from Northern Ireland has pleaded guilty at Belfast Crown Court to falsifying a clinical trial of a sleeping pill for the drug company Sanofi Aventis. Hugh McGoldrick was due to go to trial on eight charges but pleaded guilty on two of the charges after the jury was sworn in.
He admitted two counts of conducting a clinical trial of the efficacy and safety of M100907 in sleep maintenance insomnia, in breach of the Medicines for Human Use (Clinical Trials) Regulations 2004, on dates from November 2007 to June 2008. The …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial